| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 2.22e-08 | 7 | 102 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 6.01e-08 | 21 | 102 | 5 | GO:0034987 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.14e-04 | 49 | 102 | 4 | GO:0005547 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.41e-10 | 8 | 101 | 5 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 3.16e-10 | 9 | 101 | 5 | GO:0001810 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 6.30e-10 | 10 | 101 | 5 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 7.36e-09 | 15 | 101 | 5 | GO:0002885 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.50e-08 | 17 | 101 | 5 | GO:0002866 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.81e-08 | 19 | 101 | 5 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 7.99e-08 | 23 | 101 | 5 | GO:0002863 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.11e-07 | 10 | 101 | 4 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.11e-07 | 10 | 101 | 4 | GO:0002894 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 1.25e-07 | 25 | 101 | 5 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.74e-07 | 11 | 101 | 4 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.74e-07 | 11 | 101 | 4 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 1.89e-07 | 27 | 101 | 5 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 3.29e-07 | 30 | 101 | 5 | GO:0002888 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 3.74e-07 | 13 | 101 | 4 | GO:0001788 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 5.63e-07 | 99 | 101 | 7 | GO:0050766 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 7.09e-07 | 15 | 101 | 4 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 7.09e-07 | 15 | 101 | 4 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 1.88e-06 | 42 | 101 | 5 | GO:0002675 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 1.88e-06 | 42 | 101 | 5 | GO:0002438 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 2.86e-06 | 81 | 101 | 6 | GO:0002886 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 4.77e-06 | 136 | 101 | 7 | GO:0050764 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 7.98e-06 | 56 | 101 | 5 | GO:0002714 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 7.98e-06 | 56 | 101 | 5 | GO:0002891 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell activation | 9.75e-06 | 100 | 101 | 6 | GO:0050871 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 1.01e-05 | 213 | 101 | 8 | GO:0045807 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 1.22e-05 | 61 | 101 | 5 | GO:0002861 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.93e-05 | 67 | 101 | 5 | GO:0002673 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.23e-05 | 69 | 101 | 5 | GO:0006911 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 4.05e-05 | 78 | 101 | 5 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 4.31e-05 | 79 | 101 | 5 | GO:0002712 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 4.31e-05 | 79 | 101 | 5 | GO:0050853 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 4.31e-05 | 79 | 101 | 5 | GO:0002889 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 5.25e-05 | 42 | 101 | 4 | GO:0006910 | |
| GeneOntologyBiologicalProcess | phagocytosis | 6.09e-05 | 274 | 101 | 8 | GO:0006909 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 6.32e-05 | 44 | 101 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | membrane invagination | 6.85e-05 | 87 | 101 | 5 | GO:0010324 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 8.92e-05 | 148 | 101 | 6 | GO:0002444 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 1.05e-04 | 50 | 101 | 4 | GO:0045022 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 1.25e-04 | 389 | 101 | 9 | GO:0030100 | |
| GeneOntologyBiologicalProcess | regulation of B cell activation | 1.52e-04 | 163 | 101 | 6 | GO:0050864 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.53e-04 | 103 | 101 | 5 | GO:0002437 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 1.64e-04 | 56 | 101 | 4 | GO:0098927 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.43e-04 | 62 | 101 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | axonemal central apparatus assembly | 3.52e-04 | 6 | 101 | 2 | GO:1904158 | |
| GeneOntologyBiologicalProcess | complement activation | 3.88e-04 | 70 | 101 | 4 | GO:0006956 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | CD300LF HIP1R C2CD5 PTPN1 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 BTK FES | 4.23e-04 | 667 | 101 | 11 | GO:0060627 |
| GeneOntologyBiologicalProcess | B cell differentiation | 4.67e-04 | 201 | 101 | 6 | GO:0030183 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | ENTPD7 CD300LF PIR NCOR1 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 RPTOR BTK FES | 4.75e-04 | 789 | 101 | 12 | GO:0002521 |
| GeneOntologyBiologicalProcess | acute inflammatory response | 6.94e-04 | 143 | 101 | 5 | GO:0002526 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 7.74e-04 | 84 | 101 | 4 | GO:0008333 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | CD300LF AZIN2 ATP8A2 HIP1R CHRNB2 C2CD5 PTPRJ UBR5 IGHG1 IGHG2 IGHG3 IGHG4 BTK CDK1 | 7.84e-04 | 1081 | 101 | 14 | GO:0051050 |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 8.05e-04 | 223 | 101 | 6 | GO:0050851 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 8.09e-04 | 85 | 101 | 4 | GO:0019731 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 8.60e-04 | 150 | 101 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.60e-04 | 150 | 101 | 5 | GO:0002824 | |
| GeneOntologyBiologicalProcess | hemopoiesis | ENTPD7 CD300LF SPTA1 PIR NCOR1 ZBTB32 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 RPTOR BTK SNAI2 FES | 8.79e-04 | 1223 | 101 | 15 | GO:0030097 |
| GeneOntologyBiologicalProcess | lysosomal transport | 8.86e-04 | 151 | 101 | 5 | GO:0007041 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.04e-03 | 10 | 101 | 2 | GO:1990264 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.12e-03 | 159 | 101 | 5 | GO:0002821 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.17e-03 | 640 | 101 | 10 | GO:1903131 | |
| GeneOntologyBiologicalProcess | heart development | PCSK5 RPGRIP1L ACACB PTPRJ GLI1 VCAN SNAI2 FES KDM2A CDK1 ALPK2 | 1.20e-03 | 757 | 101 | 11 | GO:0007507 |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 5.36e-07 | 14 | 103 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.26e-06 | 17 | 103 | 4 | GO:0042571 | |
| MousePheno | absent memory B cells | 1.10e-09 | 4 | 82 | 4 | MP:0008094 | |
| MousePheno | decreased memory B cell number | 1.36e-07 | 9 | 82 | 4 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 3.52e-07 | 11 | 82 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 3.52e-07 | 11 | 82 | 4 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 1.05e-06 | 14 | 82 | 4 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 1.43e-06 | 15 | 82 | 4 | MP:0008099 | |
| MousePheno | enhanced humoral immune response | 2.47e-06 | 17 | 82 | 4 | MP:0020155 | |
| MousePheno | increased susceptibility to type I hypersensitivity reaction | 4.96e-06 | 43 | 82 | 5 | MP:0005596 | |
| MousePheno | abnormal IgG2c level | 6.10e-06 | 21 | 82 | 4 | MP:0020178 | |
| MousePheno | abnormal body temperature | 1.54e-05 | 137 | 82 | 7 | MP:0005535 | |
| MousePheno | increased germinal center B cell number | 3.07e-05 | 31 | 82 | 4 | MP:0008177 | |
| MousePheno | abnormal acute inflammation | 4.34e-05 | 357 | 82 | 10 | MP:0002498 | |
| MousePheno | increased acute inflammation | 4.89e-05 | 164 | 82 | 7 | MP:0005088 | |
| MousePheno | abnormal hypersensitivity reaction | 7.11e-05 | 174 | 82 | 7 | MP:0002148 | |
| MousePheno | increased plasma cell number | 8.56e-05 | 40 | 82 | 4 | MP:0008097 | |
| MousePheno | increased IgE level | 1.25e-04 | 83 | 82 | 5 | MP:0002497 | |
| MousePheno | abnormal type I hypersensitivity reaction | 1.32e-04 | 84 | 82 | 5 | MP:0002531 | |
| MousePheno | increased IgG2b level | 1.62e-04 | 47 | 82 | 4 | MP:0008501 | |
| MousePheno | increased IgG level | 1.75e-04 | 201 | 82 | 7 | MP:0002493 | |
| MousePheno | increased B cell number | 1.86e-04 | 271 | 82 | 8 | MP:0005014 | |
| MousePheno | decreased body temperature | 1.92e-04 | 91 | 82 | 5 | MP:0005534 | |
| MousePheno | abnormal definitive hematopoiesis | RBL1 SPTA1 CHRNB2 NCOR1 ZBTB32 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 BTK SNAI2 FES MMP19 | 2.32e-04 | 808 | 82 | 14 | MP:0002123 |
| MousePheno | abnormal germinal center B cell number | 2.99e-04 | 55 | 82 | 4 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 2.99e-04 | 55 | 82 | 4 | MP:0008176 | |
| MousePheno | abnormal hemopoiesis | RBL1 SPTA1 CHRNB2 NCOR1 ZBTB32 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 BTK SNAI2 FES MMP19 | 3.41e-04 | 839 | 82 | 14 | MP:0013693 |
| MousePheno | abnormal plasma cell number | 3.92e-04 | 59 | 82 | 4 | MP:0008096 | |
| MousePheno | increased immunoglobulin level | 4.12e-04 | 305 | 82 | 8 | MP:0002461 | |
| MousePheno | abnormal inflammatory response | HEXB CD300LF RBL1 SPTA1 ALS2 FRYL CERS6 LGALS3BP IGHG1 IGHG2 IGHG3 IGHG4 BTK SNAI2 FES MMP3 MMP19 HYDIN | 4.84e-04 | 1310 | 82 | 18 | MP:0001845 |
| MousePheno | abnormal lymphopoiesis | 5.69e-04 | 490 | 82 | 10 | MP:0002401 | |
| MousePheno | decreased circulating leptin level | 6.40e-04 | 118 | 82 | 5 | MP:0005668 | |
| MousePheno | abnormal leukopoiesis | CHRNB2 NCOR1 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 BTK SNAI2 FES MMP19 | 6.71e-04 | 594 | 82 | 11 | MP:0005460 |
| MousePheno | increased anti-double stranded DNA antibody level | 7.51e-04 | 70 | 82 | 4 | MP:0004762 | |
| Domain | Cell_morpho_N | 2.95e-05 | 2 | 102 | 2 | IPR025614 | |
| Domain | FAM78 | 2.95e-05 | 2 | 102 | 2 | IPR029638 | |
| Domain | Cell_Morphogen_C | 2.95e-05 | 2 | 102 | 2 | IPR025481 | |
| Domain | MOR2-PAG1_mid | 2.95e-05 | 2 | 102 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 2.95e-05 | 2 | 102 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 2.95e-05 | 2 | 102 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 2.95e-05 | 2 | 102 | 2 | PF14222 | |
| Domain | Rho_GTPase_act | 1.76e-04 | 4 | 102 | 2 | IPR015767 | |
| Domain | C1-set | 2.15e-04 | 54 | 102 | 4 | PF07654 | |
| Domain | - | 2.26e-04 | 22 | 102 | 3 | 2.130.10.30 | |
| Domain | IGc1 | 2.48e-04 | 56 | 102 | 4 | SM00407 | |
| Domain | RCC1/BLIP-II | 2.59e-04 | 23 | 102 | 3 | IPR009091 | |
| Domain | Ig/MHC_CS | 2.84e-04 | 58 | 102 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 2.84e-04 | 58 | 102 | 4 | IPR003597 | |
| Domain | IG_MHC | 3.23e-04 | 60 | 102 | 4 | PS00290 | |
| Domain | Ig-like_fold | COL12A1 CD300LF CAMTA2 IL22RA1 PTPRJ IGHG1 IGHG2 IGHG3 IGHG4 VCAN ALPK2 EPHA10 | 4.66e-04 | 706 | 102 | 12 | IPR013783 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.31e-05 | 56 | 77 | 5 | MM14815 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.64e-05 | 114 | 77 | 6 | MM14814 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 5.85e-05 | 39 | 77 | 4 | MM17212 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.33e-04 | 48 | 77 | 4 | MM17214 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.12e-04 | 54 | 77 | 4 | MM14655 | |
| Pubmed | 1.24e-12 | 6 | 103 | 5 | 29531165 | ||
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 7.25e-11 | 4 | 103 | 4 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 7.25e-11 | 4 | 103 | 4 | 11812141 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 7.25e-11 | 4 | 103 | 4 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 7.25e-11 | 4 | 103 | 4 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 7.25e-11 | 4 | 103 | 4 | 19050247 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 7.25e-11 | 4 | 103 | 4 | 30287618 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 7892607 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 7.25e-11 | 4 | 103 | 4 | 25363774 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 7.25e-11 | 4 | 103 | 4 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 7.25e-11 | 4 | 103 | 4 | 8438159 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 4098598 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 7.25e-11 | 4 | 103 | 4 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 7.25e-11 | 4 | 103 | 4 | 6803173 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6264445 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 7.25e-11 | 4 | 103 | 4 | 25867470 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 1542303 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 7.25e-11 | 4 | 103 | 4 | 9126488 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 8452816 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 4831970 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 7439686 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6278424 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 35133976 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 7.25e-11 | 4 | 103 | 4 | 32006024 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 7.25e-11 | 4 | 103 | 4 | 117549 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 116231 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 7.25e-11 | 4 | 103 | 4 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 7.25e-11 | 4 | 103 | 4 | 6801765 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6306571 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 7.25e-11 | 4 | 103 | 4 | 1713710 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 7.25e-11 | 4 | 103 | 4 | 9103199 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 7.25e-11 | 4 | 103 | 4 | 98524 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 7.25e-11 | 4 | 103 | 4 | 6799207 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6787604 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 7.25e-11 | 4 | 103 | 4 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 7.25e-11 | 4 | 103 | 4 | 6767246 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 12051834 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 7.25e-11 | 4 | 103 | 4 | 807855 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 4166666 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 26201558 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6249338 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 7.25e-11 | 4 | 103 | 4 | 19592272 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 10720538 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 24752300 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 15699144 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 2513486 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 7.25e-11 | 4 | 103 | 4 | 3921826 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 7.25e-11 | 4 | 103 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 7.25e-11 | 4 | 103 | 4 | 6766534 | |
| Pubmed | 9.41e-11 | 11 | 103 | 5 | 34586363 | ||
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 3.62e-10 | 5 | 103 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 3.62e-10 | 5 | 103 | 4 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 3.62e-10 | 5 | 103 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 3.62e-10 | 5 | 103 | 4 | 20031218 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center B cells. | 3.62e-10 | 5 | 103 | 4 | 30359469 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 9834201 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 103631 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 33163250 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 37310381 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 36853944 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 3.62e-10 | 5 | 103 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 3.62e-10 | 5 | 103 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 3.62e-10 | 5 | 103 | 4 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 3.62e-10 | 5 | 103 | 4 | 26620759 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 32640012 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 3.62e-10 | 5 | 103 | 4 | 34539636 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 3031474 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 33025844 | ||
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 3.62e-10 | 5 | 103 | 4 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 3.62e-10 | 5 | 103 | 4 | 24548411 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 3.62e-10 | 5 | 103 | 4 | 6781756 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 3.62e-10 | 5 | 103 | 4 | 9743367 | |
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 3.62e-10 | 5 | 103 | 4 | 16301663 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 9707605 | ||
| Pubmed | 1.08e-09 | 6 | 103 | 4 | 27457619 | ||
| Pubmed | 1.08e-09 | 6 | 103 | 4 | 30705065 | ||
| Pubmed | 1.08e-09 | 6 | 103 | 4 | 27769169 | ||
| Pubmed | PLC-gamma2 is essential for formation and maintenance of memory B cells. | 1.08e-09 | 6 | 103 | 4 | 19273623 | |
| Interaction | IGHV4-31 interactions | 6.72e-06 | 8 | 101 | 3 | int:IGHV4-31 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.02e-08 | 74 | 98 | 7 | Arv_SC-HD_1000_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.05e-08 | 76 | 98 | 7 | Arv_SC_fibroblast_1000_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 4.22e-06 | 24 | 98 | 4 | Arv_SC-H9hpx_500_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#3 | 1.58e-05 | 33 | 98 | 4 | Arv_SC-hpx_blastocyst_500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.37e-05 | 74 | 98 | 5 | Arv_SC-H9hpx_1000_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.77e-05 | 89 | 98 | 5 | Arv_SC-hpx_blastocyst_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#5 | 1.19e-04 | 21 | 98 | 3 | Arv_SC-HD_500_K5 | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 1.95e-08 | 197 | 103 | 8 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B|COVID-19_Severe / Disease, condition lineage and cell class | 2.03e-08 | 198 | 103 | 8 | 1831a777dd996c25f637d551d754ec1b9c23feb2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B|COVID-19_Mild / Disease, condition lineage and cell class | 2.20e-08 | 200 | 103 | 8 | 11b51dfca161342d92126e0a83d10864348ba3ef | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.78e-08 | 145 | 103 | 7 | 34cff6df39ff05995041f0c231c60a50ad1a0c1c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-08 | 158 | 103 | 7 | 6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-08 | 158 | 103 | 7 | 8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888 | |
| ToppCell | IIF-Lymphocyte-B-Plasmablast|IIF / Disease, Lineage and Cell Type | 9.79e-08 | 161 | 103 | 7 | 4d78985e7b11e92591e75a4864fd769882db2d1c | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 9.79e-08 | 161 | 103 | 7 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | Bronchial_Biopsy-Immune-B_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.21e-07 | 166 | 103 | 7 | 22e94546b264c87cb55928d1591bf1b5ee2a76bd | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 1.31e-07 | 168 | 103 | 7 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-07 | 170 | 103 | 7 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.73e-07 | 175 | 103 | 7 | fa53ea81ad943a2cd266114829135cbcbcf2f634 | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 1.73e-07 | 175 | 103 | 7 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-07 | 179 | 103 | 7 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-07 | 179 | 103 | 7 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-07 | 179 | 103 | 7 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 181 | 103 | 7 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 181 | 103 | 7 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.34e-07 | 183 | 103 | 7 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 2.71e-07 | 187 | 103 | 7 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.81e-07 | 188 | 103 | 7 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.91e-07 | 189 | 103 | 7 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-07 | 189 | 103 | 7 | 0994aba7a44577a8943af237c9c3575502d0584c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-07 | 189 | 103 | 7 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-07 | 189 | 103 | 7 | d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658 | |
| ToppCell | COPD|World / Disease state, Lineage and Cell class | 2.91e-07 | 189 | 103 | 7 | 53577632683686dc493a5a3fdc01887ec5c320f2 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 3.02e-07 | 190 | 103 | 7 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-07 | 190 | 103 | 7 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-07 | 191 | 103 | 7 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Control-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.13e-07 | 191 | 103 | 7 | 076302fd247aab6c0b187ac9e0c67a3ba46414ba | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.13e-07 | 191 | 103 | 7 | b23fdcd3090df9f58310b4dc8f7dc0c6d6b33226 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.24e-07 | 192 | 103 | 7 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 3.24e-07 | 192 | 103 | 7 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 3.24e-07 | 192 | 103 | 7 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-07 | 192 | 103 | 7 | e33579a20ca86dcaf02c97273681ba5eee7561b8 | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 3.35e-07 | 193 | 103 | 7 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-07 | 193 | 103 | 7 | 325859399411d0e66a78a385dffa886df9af3198 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.35e-07 | 193 | 103 | 7 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-07 | 193 | 103 | 7 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.35e-07 | 193 | 103 | 7 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-07 | 194 | 103 | 7 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 3.47e-07 | 194 | 103 | 7 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.47e-07 | 194 | 103 | 7 | 7dbedbdece4271e10134c9338c85cb3e04484c75 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 194 | 103 | 7 | fb850d99bc1ce52c9ea8080199e6322902fd63a0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-07 | 194 | 103 | 7 | c531c1759a3dfbc85d00ed5eaba35cd14b1b2ac1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-07 | 194 | 103 | 7 | bd2c53fb064edfec76abe56a9ffaced0bda32ab0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.47e-07 | 194 | 103 | 7 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 3.72e-07 | 196 | 103 | 7 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.72e-07 | 196 | 103 | 7 | 279f113916dcb398111d787ae06bcf20ff8febd2 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-B_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.72e-07 | 196 | 103 | 7 | a2759691606b03de9d67e8d38487915cd4e7d448 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-B_cell-B_cell-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-07 | 196 | 103 | 7 | b4e815f198eac3256302488750e352b436d632f0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-07 | 196 | 103 | 7 | fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-07 | 196 | 103 | 7 | 04a09f99c59b1ae8f72d85505b88f88cbe748260 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.85e-07 | 197 | 103 | 7 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.85e-07 | 197 | 103 | 7 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-07 | 198 | 103 | 7 | 702038a0278bffe4276354efc2318c80dc42b9b0 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_mature|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-07 | 199 | 103 | 7 | 074f21a0075ff6c8e634dc4b12699d371d5f720a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-07 | 199 | 103 | 7 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class | 4.12e-07 | 199 | 103 | 7 | 54e392b4ebe601d4838739ff7de3ac6b2203c948 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-07 | 199 | 103 | 7 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-07 | 199 | 103 | 7 | e9bdc7e9b841ea5aad2f08e7cc9929d824852718 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 200 | 103 | 7 | e1b3fc516887510b18cf688ada0e00b5f5eff684 | |
| ToppCell | Control-Control-Lymphocyte-B|Control / Disease, condition lineage and cell class | 4.26e-07 | 200 | 103 | 7 | d95551392de7316b72eacf1e4a1cb23452991fa0 | |
| ToppCell | Sigmoid-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 4.26e-07 | 200 | 103 | 7 | 2071a71b6fba403f55becddc0434d56a0b598c8e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 149 | 103 | 6 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 1.47e-06 | 152 | 103 | 6 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-06 | 157 | 103 | 6 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-06 | 157 | 103 | 6 | 2cb3deb5313ce734710c601935ca318e4179077e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 158 | 103 | 6 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 158 | 103 | 6 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 158 | 103 | 6 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 158 | 103 | 6 | ad1040bce6ad655c2502d9abb02507ecff177f83 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 158 | 103 | 6 | ac7aef01eda1dca80d6c5b508649fcad55803a67 | |
| ToppCell | Influenza_Severe-B_memory|World / Disease group and Cell class | 2.13e-06 | 162 | 103 | 6 | 21eb96cd4fecd85dd6acbbc3760944fa1a7cff42 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 2.21e-06 | 163 | 103 | 6 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 2.63e-06 | 168 | 103 | 6 | e8bd090de5c9fe286b08a8b314ce12cf988184f0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.66e-06 | 94 | 103 | 5 | 4b6623de5a517ebf5df865e0dcd615111622ad3e | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-06 | 169 | 103 | 6 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-06 | 169 | 103 | 6 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.72e-06 | 169 | 103 | 6 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.72e-06 | 169 | 103 | 6 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-06 | 170 | 103 | 6 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-06 | 170 | 103 | 6 | 7377e59fba4bf97ba893ccf6b5e149b5152407be | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_memory|Bac-SEP / Disease, Lineage and Cell Type | 2.81e-06 | 170 | 103 | 6 | 86db153984437ef1447eae8ef30a40be0925ffd5 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-06 | 170 | 103 | 6 | e18211029e9ffad54458fd921f455172aad407c7 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class （2021.01.30） | 2.91e-06 | 171 | 103 | 6 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.01e-06 | 172 | 103 | 6 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.11e-06 | 173 | 103 | 6 | 9082ad77b44f65b72094df6e502cce81b62fe81a | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 3.22e-06 | 174 | 103 | 6 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-06 | 175 | 103 | 6 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 3.32e-06 | 175 | 103 | 6 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-06 | 175 | 103 | 6 | c3d3f11602379aaba65842a98835299e54fccd84 | |
| ToppCell | BAL-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.44e-06 | 176 | 103 | 6 | 7c1ecec45b5fe5e73cbce0fadca726ffd10c0316 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.67e-06 | 178 | 103 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-06 | 178 | 103 | 6 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-06 | 178 | 103 | 6 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-06 | 178 | 103 | 6 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 3.91e-06 | 180 | 103 | 6 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 4.04e-06 | 181 | 103 | 6 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.04e-06 | 181 | 103 | 6 | 0bc58c8942491e7ee5b858c5742770df7677532f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.67e-06 | 50 | 56 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.18e-04 | 49 | 56 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG | |
| Disease | insulin growth factor-like family member 4 measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0801701 | |
| Disease | neural cell adhesion molecule 1 measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0801826 | |
| Disease | immunoglobulin G measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0020465 | |
| Disease | secretoglobin family 1C member 1 measurement | 3.27e-05 | 3 | 98 | 2 | EFO_0802041 | |
| Disease | ameloblastin measurement | 3.27e-05 | 3 | 98 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 3.27e-05 | 3 | 98 | 2 | EFO_0801866 | |
| Disease | trem-like transcript 4 protein measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0802160 | |
| Disease | di-N-acetylchitobiase measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0801524 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0802027 | |
| Disease | energy expenditure | 9.81e-05 | 27 | 98 | 3 | EFO_0005109 | |
| Disease | blood strontium measurement | 9.81e-05 | 27 | 98 | 3 | EFO_0021531 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 1.08e-04 | 5 | 98 | 2 | EFO_0801901 | |
| Disease | Myositis, Proliferative | 1.08e-04 | 5 | 98 | 2 | C0544796 | |
| Disease | Myositis | 1.08e-04 | 5 | 98 | 2 | C0027121 | |
| Disease | Infectious Myositis | 1.08e-04 | 5 | 98 | 2 | C0158353 | |
| Disease | protein shisa-3 homolog measurement | 1.08e-04 | 5 | 98 | 2 | EFO_0801964 | |
| Disease | Myositis, Focal | 1.08e-04 | 5 | 98 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 1.08e-04 | 5 | 98 | 2 | C0751356 | |
| Disease | complement C1q subcomponent measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0008089 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0801810 | |
| Disease | inducible T-cell costimulator measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0021967 | |
| Disease | axin-2 measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0801400 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 4.86e-04 | 46 | 98 | 3 | EFO_0008003, GO_0097332 | |
| Disease | Primary Ciliary Dyskinesia | 5.18e-04 | 47 | 98 | 3 | C4551720 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.86e-04 | 49 | 98 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 8.32e-04 | 13 | 98 | 2 | EFO_0010617 | |
| Disease | cocaine dependence | 9.60e-04 | 58 | 98 | 3 | EFO_0002610 | |
| Disease | cortical surface area measurement | HEXB ATP8A2 SRPK2 FRYL PTPN1 NCOR1 CLCN2 VCAN FES MTCL1 ARHGAP27 CTSO | 1.67e-03 | 1345 | 98 | 12 | EFO_0010736 |
| Disease | lateral orbital frontal cortex volume measurement | 2.87e-03 | 24 | 98 | 2 | EFO_0010312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYTFSGLTLSPKPWI | 121 | Q6NS38 | |
| WIHTDASLVYPTFGP | 136 | Q6UX73 | |
| SATYGVEAGVVPWLS | 2981 | P13611 | |
| TWVEDTYLPPIFSSL | 446 | A6NCI8 | |
| YTSSVGSKFPVRWSP | 551 | Q06187 | |
| EVYSFGTLPWRSGPV | 61 | Q96Q42 | |
| ASYSSIVSFPWEKPT | 976 | Q86TB3 | |
| STEQPLYSSSLWGPA | 346 | Q96A70 | |
| NFYPSVTWAVPVSDS | 141 | Q5VT40 | |
| ALSTITDFSPEWSYP | 531 | O94983 | |
| ITGVYPASPSSWLIV | 51 | P50416 | |
| APDPDWASYTLGVFI | 26 | O75689 | |
| VVTWSRPYFLGTGSI | 326 | Q8WYQ5 | |
| SERFEGPYTDFTPWT | 541 | Q99543 | |
| LSPAAGYVIVSSVSW | 26 | Q8IUH2 | |
| FFGIYSTIWPTIPIA | 1041 | Q9NTI2 | |
| PLYLEWAPVGVFSST | 651 | Q9Y4C8 | |
| ITSPTGETWTIPVYS | 301 | Q2TAL8 | |
| TEPFPDSSWYLTTSV | 1466 | Q9Y4B5 | |
| LLYGESPWGVTPISF | 621 | O00763 | |
| FFTSEPPSIYQWVSS | 836 | Q9H1A4 | |
| WPSFITYTVGVLDPA | 1741 | Q8TEM1 | |
| QAGSSIPSTWPRFYD | 256 | Q8IV08 | |
| SYVFSITPGIGNETW | 181 | Q12913 | |
| YTTWPDFGVPESPAS | 176 | P18031 | |
| PRIYTSPTWSAFVTD | 406 | Q08380 | |
| PASWYFTVPTVSPFL | 11 | Q9NQZ7 | |
| EVFTVGPKTFSWTPF | 76 | Q6NZ36 | |
| WKFAYLPPSGSITTE | 916 | Q68CZ1 | |
| EAEITISFPTFWSPS | 2351 | Q15751 | |
| DPSFSPVSWSISGKY | 3486 | Q15751 | |
| SFWPSLPSGVDAAYE | 331 | P08254 | |
| WSLVLYGTSVQPYSP | 591 | Q92824 | |
| YVWTVSDSGPGPLFR | 311 | Q99542 | |
| WSPLVDYVPETSSPG | 1576 | O94915 | |
| IPKGWTSFIYTISGD | 186 | O00625 | |
| WKPPTYLFSTDGTEE | 596 | Q8IY47 | |
| AWSFYDDVTVPSPPS | 286 | Q86W50 | |
| VPAAVVWLSYGVASS | 36 | Q9UDX5 | |
| SYPDPTQETWGEFPS | 771 | P08151 | |
| WPVPILVTTAAAFAY | 86 | Q8WTR4 | |
| TYAQVTVSTGPGAPW | 441 | Q5JZY3 | |
| WGASPSYTILSVVSF | 186 | Q96P66 | |
| PGVYTSVATYSPWIQ | 261 | Q8NF86 | |
| PFPWSFYTASVFIGI | 96 | O43934 | |
| AVPGTVWTAGFVLTY | 211 | Q96ES6 | |
| PTFDTITYEWAPPGV | 111 | Q9NZU5 | |
| PYVDPFTTVTLGWPD | 571 | Q7Z442 | |
| SSPAVAPDLFWGTYR | 86 | Q13724 | |
| FLTGYVWSAVTPSPE | 356 | O00750 | |
| TYTDTGLPSYPWILT | 66 | Q6MZM9 | |
| TFWSYAIGLPLPSSS | 66 | O75146 | |
| VWAYPTSVGVFEDSI | 2896 | Q4G0P3 | |
| FVIPSGWIHAVYTPT | 276 | Q9Y2K7 | |
| ITDTSIGAYWTSAPG | 916 | Q99715 | |
| LPSSLDFWTYPGSLT | 186 | P00915 | |
| SPSAWYVPFVITLGS | 706 | Q6ZTQ4 | |
| FWLSGYSIVTQITGP | 11 | Q8TDQ1 | |
| LEPGEYPTSEAWGTS | 1131 | Q8N1P7 | |
| TTLFESWEIVGPYPS | 286 | Q6ZMG9 | |
| IPLEFGSQTPWTTGY | 76 | P59910 | |
| WDSGPEGTPDTVYSI | 41 | Q8N6P7 | |
| DYFPEPVTVSWNSGA | 31 | P01857 | |
| DYFPEPVTVSWNSGA | 31 | P01859 | |
| DYFPEPVTVSWNSGA | 31 | P01860 | |
| DYFPEPVTVSWNSGA | 31 | P01861 | |
| PLYSDGAWSEPTFTS | 2886 | Q5TBA9 | |
| VTASGFPVILSAPWY | 436 | P07686 | |
| AATVISGWFPIYDTI | 101 | Q86YS7 | |
| WETFSLGASPYPNLS | 751 | P07332 | |
| GFSWAIVPALTSLGY | 11 | P0DP42 | |
| SWPSSYGDTPTVSIK | 251 | Q8N9U0 | |
| NFYPSVTWAVPVSES | 161 | Q5JUQ0 | |
| FAYSSPRTFPWIIEV | 511 | P28749 | |
| DFDGTRVYSPPEWIS | 196 | Q9P1W9 | |
| WEDRPSSTGSTQFPY | 2371 | O75376 | |
| SLYSLFEGTPWSPSL | 976 | Q92540 | |
| YNPDTGVTTWESPFE | 266 | Q6ZUM4 | |
| GAYSPITVWTTAAPF | 51 | O43623 | |
| SPETLSDQPWYFSGV | 111 | Q9H3Y6 | |
| PWAVSLALSVGIFPY | 461 | Q8N122 | |
| SVGVWTAISPYLSGV | 86 | Q96N87 | |
| VVSYDGSIFWLPPAI | 136 | P17787 | |
| VLITGFDKTGSTPYW | 271 | P43234 | |
| YSTPVDIWSIGTIFA | 181 | P06493 | |
| AWVTYPVVLITFSAG | 136 | P51788 | |
| SGPILTVSLFGRWYT | 471 | O95498 | |
| TYPPDLTSVFIWETL | 246 | Q9NYW4 | |
| FDPGYEPDWAVISTV | 81 | Q9HA65 | |
| ESYPSSSPIWFVDSE | 61 | Q8WVN8 | |
| PDPRSRYTFWTFVVG | 236 | Q92911 | |
| WRSPALFIYTSGTTG | 286 | Q9Y2P5 | |
| FLTPAVTPTWYAGSG | 16 | O60687 | |
| TVAWFLYSAPGVDPS | 6 | A6NNV3 | |
| PSESWEFPGFTRQAY | 46 | A6NCN8 | |
| TVAWFLYSAPGVDPS | 6 | Q8NFV5 | |
| LIGAGYSTPADIWST | 556 | P78362 | |
| GPSWVVLTGNSLVFY | 346 | Q9BRR9 | |
| ALGVPSSPYTWLTVE | 2111 | P02549 | |
| FPDSRSPGLYTTWTL | 446 | Q8TEC5 | |
| TVAWFLYSAPGVDPS | 6 | A6NJR5 | |
| PPGWTIRSTFLYSSS | 456 | Q9Y2Y4 | |
| VSWTTVFLAEYTGPL | 141 | Q5HYJ1 | |
| YEAEFTSPSWPSTSP | 21 | Q15849 | |
| YFWTSSPSLPASEEG | 2731 | O95071 |